Clinical Trials Sponsored by Susan G. Komen Breast Cancer Foundation

Total 69 results

Susan G. Komen Breast Cancer Foundation

Recruiting

Susan G. Komen's ShareForCures

Breast Cancer

United States
Duke University
Susan G. Komen Breast Cancer Foundation

Completed

Telemedicine vs. Face-to-Face Cancer Genetic Counseling

Lynch Syndrome | Hereditary Breast and Ovarian Cancer Syndrome

United States
Mayo Clinic
Susan G. Komen Breast Cancer Foundation

Completed

Flaxseed for the Treatment of Hot Flashes

Hot Flashes

United States
Hartford Hospital
Susan G. Komen Breast Cancer Foundation

Completed

Changes in Biomarkers Using Prostaglandin Inhibitors

Biomarker Change Linked to Breast Cancer

United States
Mayo Clinic
Susan G. Komen Breast Cancer Foundation

Completed

Molecular Breast Imaging in Women With Atypia and LCIS

Lobular Carcinoma in Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia

United States
Mayo Clinic
Susan G. Komen Breast Cancer Foundation

Completed

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Breast Cancer

United States
Stanford University
Susan G. Komen Breast Cancer Foundation

Completed

Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study

Breast Cancer

United States
Mercy Medical Center
Susan G. Komen Breast Cancer Foundation

Completed

An Intervention to Decrease Fatigue Among Breast Cancer Survivors

Fatigue After Adjuvant Breast Cancer Treatment

United States
Columbia University
Susan G. Komen Breast Cancer Foundation

Completed

Post-treatment Care of Breast Cancer Survivors

Breast Neoplasm

United States
Emory University
Susan G. Komen Breast Cancer Foundation

Withdrawn

Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH

Breast Cancer

United States
Mayo Clinic
Susan G. Komen Breast Cancer Foundation

Completed

Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Breast Cancer

United States
Mayo Clinic
Susan G. Komen Breast Cancer Foundation

Completed

Pre-biopsy With Dynamic Acquisitions

Breast Cancer

United States
M.D. Anderson Cancer Center
Susan G. Komen Breast Cancer Foundation

Terminated

Exemestane-RAD001-Metformin

Breast Cancer

United States
Jonsson Comprehensive Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors

Fatigue

United States
M.D. Anderson Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

The Impact of Obesity and Obesity Treatments on Breast Cancer

Breast Cancer

United States
Jonsson Comprehensive Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors

Younger Breast Cancer Survivors

United States
M.D. Anderson Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases

Breast Cancer

United States
Stanford University
Susan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation

Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

Breast Cancer | Ovarian Cancer | Gynecologic Cancers | Ovarian/Peritoneal/Fallopian Cancer

United States
M.D. Anderson Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

Delayed-Immediate Breast Reconstruction

Breast Cancer

United States
University at Buffalo
Susan G. Komen Breast Cancer Foundation

Completed

The Jewels in Our Genes Study - an African American Family Study of Breast Cancer

Breast Cancer

United States
Jonsson Comprehensive Cancer Center
Susan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation

Completed

Project Connect Online: An Internet-based Intervention for Women With Breast Cancer (PCO)

Breast Neoplasms

United States
University of Alberta
Susan G. Komen Breast Cancer Foundation

Completed

Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects (CREATE)

Breast Cancer Female

Canada
UConn Health
Susan G. Komen Breast Cancer Foundation; Hollfelder foundation

Terminated

Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

Cancer-related Fatigue

United States
OHSU Knight Cancer Institute
Susan G. Komen Breast Cancer Foundation

Completed

Strength Training for Older Breast Cancer Survivors

Breast Neoplasm | Osteoporosis, Postmenopausal

United States
Roswell Park Cancer Institute
Susan G. Komen Breast Cancer Foundation

Recruiting

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Breast Carcinoma | Healthy Subject

United States
Dana-Farber Cancer Institute
Susan G. Komen Breast Cancer Foundation

Recruiting

Elevate! : An Elderly Breast Cancer Cohort Study

Breast Cancer

United States
Tufts Medical Center
Axcan Pharma; Susan G. Komen Breast Cancer Foundation

Completed

Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma (CLIPT)

Breast Cancer | Skin Cancer

United States
University of South Carolina
Susan G. Komen Breast Cancer Foundation

Completed

Brown Seaweed as a Breast Cancer Preventive

Breast Cancer

United States
Masonic Cancer Center, University of Minnesota
Susan G. Komen Breast Cancer Foundation

Completed

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Breast Cancer | Postmenopausal Bone Loss

United States
H. Kim Lyerly
Susan G. Komen Breast Cancer Foundation

Completed

A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901

HER2+ Cancer

United States
Columbia University
Astellas Pharma Inc; Susan G. Komen Breast Cancer Foundation

Completed

Study of Erlotinib and Metformin in Triple Negative Breast Cancer

Breast Cancer

United States
Washington University School of Medicine
Susan G. Komen Breast Cancer Foundation

Withdrawn

Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer
Washington University School of Medicine
Susan G. Komen Breast Cancer Foundation

Completed

Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy

Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer

United States
Sonya Reid
Susan G. Komen Breast Cancer Foundation; Agendia

Recruiting

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort (INSIGHT)

Metastatic Breast Cancer | Invasive Mammary Carcinoma

United States
Dana-Farber Cancer Institute
Susan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation; Terri...

Active, not recruiting

DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC

Breast Cancer

United States
Mayo Clinic
National Cancer Institute (NCI); Susan G. Komen Breast Cancer Foundation

Active, not recruiting

Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue

Breast Carcinoma

United States
Dana-Farber Cancer Institute
Yale University; Susan G. Komen Breast Cancer Foundation

Active, not recruiting

The Preoperative Health & Body Study (PreHab)

Breast Cancer

United States
M.D. Anderson Cancer Center
Bristol-Myers Squibb; Susan G. Komen Breast Cancer Foundation

Active, not recruiting

Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

Breast Cancer

United States
Indiana University
University of Wisconsin, Madison; Susan G. Komen Breast Cancer Foundation

Completed

iMETX (Individualized Metabolic RX): a Pilot Study

Breast Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Susan G. Komen Breast Cancer Foundation

Recruiting

Johns Hopkins Breast Cancer Program Longitudinal Repository

Breast Cancer | Benign Breast Disease

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Susan G. Komen Breast Cancer Foundation

Active, not recruiting

Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database

Breast Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Susan G. Komen Breast Cancer Foundation

Completed

Involving Family to Improve Communication in Breast Cancer Care

Active Breast Cancer Treatment

United States
UNC Lineberger Comprehensive Cancer Center
GlaxoSmithKline; Genentech, Inc.; Susan G. Komen Breast Cancer Foundation

Completed

Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib

Breast Neoplasms

United States
H. Lee Moffitt Cancer Center and Research Institute
Susan G. Komen Breast Cancer Foundation

Completed

Liposuction for Arm Lymphedema Following Breast Cancer Surgery

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); Susan G. Komen Breast Cancer Foundation

Terminated

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Carol Fabian, MD
Susan G. Komen Breast Cancer Foundation

Completed

Protocol for Women at Increased Risk of Developing Breast Cancer

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); Susan G. Komen Breast Cancer Foundation

Completed

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute
Gateway for Cancer Research; Susan G. Komen Breast Cancer Foundation

Active, not recruiting

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

Breast Cancer

United States
University of California, San Francisco
Susan G. Komen Breast Cancer Foundation; California Breast Cancer Research...

Completed

Breast Cancer Risk Reduction: A Patient Doctor Intervention (BreastCARE)

Breast Cancer

United States

Clinical Trials Sponsored by Susan G. Komen Breast Cancer Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations